GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Affymetrix Inc (NAS:AFFX) » Definitions » E10

Affymetrix (Affymetrix) E10 : $-0.67 (As of Dec. 2015)


View and export this data going back to . Start your Free Trial

What is Affymetrix E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Affymetrix's adjusted earnings per share data for the three months ended in Dec. 2015 was $0.051. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-0.67 for the trailing ten years ended in Dec. 2015.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-05-05), Affymetrix's current stock price is $14.01. Affymetrix's E10 for the quarter that ended in Dec. 2015 was $-0.67. Affymetrix's Shiller PE Ratio of today is .


Affymetrix E10 Historical Data

The historical data trend for Affymetrix's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affymetrix E10 Chart

Affymetrix Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.41 -0.42 -0.47 -0.57 -0.67

Affymetrix Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.57 -0.60 -0.61 -0.63 -0.67

Competitive Comparison of Affymetrix's E10

For the Diagnostics & Research subindustry, Affymetrix's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Affymetrix's Shiller PE Ratio Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Affymetrix's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Affymetrix's Shiller PE Ratio falls into.



Affymetrix E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Affymetrix's adjusted earnings per share data for the three months ended in Dec. 2015 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2015 (Change)*Current CPI (Dec. 2015)
=0.051/99.7924*99.7924
=0.051

Current CPI (Dec. 2015) = 99.7924.

Affymetrix Quarterly Data

per share eps CPI Adj_EPS
200603 0.030 84.298 0.036
200606 -0.150 85.606 -0.175
200609 -0.210 85.606 -0.245
200612 0.128 85.142 0.150
200703 -0.060 86.640 -0.069
200706 0.020 87.906 0.023
200709 0.040 87.964 0.045
200712 0.100 88.616 0.113
200803 0.580 90.090 0.642
200806 -0.050 92.320 -0.054
200809 -0.460 92.307 -0.497
200812 -4.646 88.697 -5.227
200903 -0.370 89.744 -0.411
200906 0.110 91.003 0.121
200909 -0.130 91.120 -0.142
200912 0.040 91.111 0.044
201003 -0.140 91.821 -0.152
201006 -0.080 91.962 -0.087
201009 0.010 92.162 0.011
201012 0.058 92.474 0.063
201103 0.000 94.283 0.000
201106 -0.050 95.235 -0.052
201109 -0.140 95.727 -0.146
201112 -0.207 95.213 -0.217
201203 -0.060 96.783 -0.062
201206 0.330 96.819 0.340
201209 -0.250 97.633 -0.256
201212 -0.174 96.871 -0.179
201303 -0.220 98.209 -0.224
201306 -0.090 98.518 -0.091
201309 -0.060 98.790 -0.061
201312 0.130 98.326 0.132
201403 -0.140 99.695 -0.140
201406 -0.010 100.560 -0.010
201409 0.030 100.428 0.030
201412 0.070 99.070 0.071
201503 0.060 99.621 0.060
201506 0.080 100.684 0.079
201509 -0.070 100.392 -0.070
201512 0.051 99.792 0.051

Add all the adjusted EPS together and divide 10 will get our e10.


Affymetrix  (NAS:AFFX) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Affymetrix E10 Related Terms

Thank you for viewing the detailed overview of Affymetrix's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Affymetrix (Affymetrix) Business Description

Traded in Other Exchanges
N/A
Address
Affymetrix Inc was incorporated in California in 1992 and reincorporated in Delaware in 1998. The Company is a provider of life science tools and molecular diagnostic products that enable parallel analysis of biological systems at the gene, protein and cell level. It sells its products to genomic research centers, academic institutions, government and private laboratories, as well as pharmaceutical, diagnostic and biotechnology companies. The Companys operations consist of two reportable segments, Affymetrix Core and eBioscience. Affymetrix Core is divided into three business units with each business unit having its own research, development and marketing groups to better serve customers and respond quickly to the market needs. The three business units that form Affymetrix Core are; Expression, Genetic Analysis and Clinical Applications, and Life Science Reagents. Expression: This business unit develops and markets the Company's GeneChip gene expression products and services, and the QuantiGene line of low-to-mid-plex RNA measurement products; Genetic Analysis and Clinical Applications. This business unit develops and markets the Company's genotyping, such as the Axiom product line and clinical research applications, such as the CytoScan cytogenetics; Life Science Reagents; This business unit develops and sells reagents, enzymes, purification kits and biochemicals used by life science researchers. eBioscience; This reportable segment specializes in the development, manufacturing, marketing and distribution of research tools in the areas of flow cytometry, immunoassays, microscopic imaging and other protein-based analyses. The Company markets and distributes its products directly to customers in North America, Japan and major European markets. The Company is facing competition as existing companies develop new or improved products, and as companies enter the market with new technologies, such as next-generation sequencing. In the highly multiplexed genotyping and gene expression markets, existing competitive technologies include DNA sequencing, which the Company does not offer and is offered by companies such as Illumina, Inc., Life Technologies Corporation and Pacific Biosciences of California, Inc. The Companys operations are subject to complex and stringent environmental, health, safety and other governmental laws and regulations.
Executives
Nelson C Chan director C/O SYNAPTICS INCORPORATED, 1251 MCKAY DRIVE, SAN JOSE CA 95131
Merilee Raines director IDEXX LABORATORIES, INC., ONE IDEXX DRIVE, WESTBROOK ME 04092
Gary S Guthart director C/O INTUITIVE SURGICAL INC, 1266 KIFER RD, SUNNYVALE CA 94086
Jami K Nachtsheim director
Riccardo Pigliucci director 9640 TOWNE CENTRE DR, SAN DIEGO CA 92121
Andrew J. Last officer: EVP, Chief Operating Officer 3420 CENTRAL EXPRESSWAY, SANTA CLARA CA 95051
Gavin Wood officer: EVP, Chief Financial Officer C/O ADAPTIMMUNE THERAPEUTICS PLC, 60 JUBILEE AVE, MILTON PARK, ABINGDON, OXFORDSHIRE X0 OX14 4RX
Frank Witney director, officer: President and CEO 940 WINTER STREET, C/O PERKINELMER, WALTHAM MA 02451
Fodor Stephen P A director C/O AFFYMETRIX INC, 3420 CENTRAL EXPRESSWAY, SANTA CLARA CA 95051
Robert Paul Wayman director C/O HEWLETT-PACKARD COMPANY, 3000 HANOVER STREET, PALO ALTO CA 94304
Timothy C Barabe officer: Chief Financial Officer C/O ARQULE, INC., 1 WALL STREET, 6TH FLOOR, BURLINGTON MA 01803
Runkel John F Jr officer: EVP and General Counsel C/O INTUITIVE SURGICAL, INC., 1266 KIFER ROAD, SUNNYVALE CA 94086
John D Diekman director C/O 5 AM VENTURES, 501 2ND STREET, SUITE 350, SAN FRANCISCO CA 94107
Kevin M King officer: President and CEO C/O AFFYMETRIX, INC., 3420 CENTRAL EXPRESSWAY, SANTA CLARA CA 95051
Paul Berg director STANFORD UNIVERSITY SCHOOL OF MEDICINE, #B062, STANFORD CA 94305

Affymetrix (Affymetrix) Headlines

From GuruFocus

Affymetrix Inc. Reports Operating Results (10-Q)

By gurufocus 10qk 05-06-2010

Affymetrix Inc. (AFFX) CFO Timothy C Barabe buys 5,000 Shares

By GuruFocus Research GuruFocus Editor 11-19-2010

Affymetrix Inc. (AFFX) CFO Timothy C Barabe buys 10,000 Shares

By GuruFocus Research GuruFocus Editor 08-24-2010